Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tiny study probes Electroacupuncture's immune effects in shingles

NCT ID NCT06643247

Knowledge-focused Sponsor: First People's Hospital of Hangzhou Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how electroacupuncture might affect immune cells in people with shingles (herpes zoster). Researchers will compare standard medication alone versus medication plus electroacupuncture in 8 women aged 50-70. The goal is to see if electroacupuncture changes immune cell levels, which could help explain how it eases pain and speeds recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Electroacupuncture
What this could lead to
If it works, this could point toward a better understanding of how electroacupuncture helps the immune system fight shingles and reduce pain.
What could go wrong
This is a very small, early study with only 8 participants. It is designed to observe immune changes, not to prove a treatment works. Results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 8 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2024

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 70 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria for HZ: * Meets HZ diagnostic criteria; * Female, aged between 50 and 70 years; * Disease duration ≤7 days, with no prior antiviral, analgesic, or other treatments; * Herpetic lesions limited to the trunk, within 1 to 3 dermatomes; * Willing to participate in the trial and has signed the informed consent form. Inclusion Criteria for HC: * No history of HZ or major cardiovascular, respiratory, digestive, urinary, hematologic, endocrine, or neurological diseases; * Age-matched female HC volunteers for the HZ group; * Clear consciousness and ability to communicate normally; * Fully understands the study protocol, demonstrates good compliance, and is willing to cooperate with the study; * Has signed a written informed consent form. Exclusion Criteria: * Special types of herpes zoster, including ophthalmic, otic, visceral, meningeal herpes zoster, and zoster sine herpete; * Women who are planning to conceive, pregnant, or breastfeeding; * Patients with severe primary diseases of the circulatory, respiratory, or endocrine systems, or systemic failure; * Patients with bleeding tendencies; * Use of corticosteroids or immunosuppressants within the past month.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Electroacupuncture are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

herpes zoster immune system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Electroacupuncture Herpes zoster IMMUNE

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • The Affiliated Hangzhou First People's Hospital

    RECRUITING

    Hangzhou, Zhejiang, 310053, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.